The Alzheimer Society Research Portal connects researchers with Canadians looking to participate in research studies. On this website, find active studies that you can participate in to help advance research on dementia.
The objective of this study is to better understand caregivers’ perspectives regarding the pharmacological management of the behavioral and psychological symptoms of dementia (BPSD). While current recommendations are largely based on the opinions of healthcare professionals and experts, the viewpoint of caregivers remains underexplored. By better understanding their experience, we hope to contribute to improved guidelines and care for individuals with neurocognitive disorders.
Our research team is looking to investigate social cognitive dementia-related changes through informal caregivers lived experiences. We are interested in understanding what social cognitive changes caregivers are seeing in their loved one with dementia, how frequent and severe these changes are, and how these changes are affecting informal caregivers' wellbeing. Information gathered will be used to learn what knowledge caregivers have, the changes that are impacting them and their loved ones the most, and we will develop educational resources to help support caregivers in a meaningful way.
Are 18 years of age or more.
Are an informal, unpaid caregiver to a loved one with dementia (any form).
Reside and provide care in Canada.
To sign up, scan the QR code [on the flyer] or email [email protected] and the research team will send a link to the online survey, which is available in both English and French. Those who complete the survey will be entered in a draw to win one of 50, $60 e-gift cards.
The aim of this study is to understand how people with dementia, family/friend carers and healthcare providers experience the Driving and Dementia Roadmap website. This website contains resources to help people in the decision-making about when to stop driving and adjust to life after driving. We are also interested in knowing how the Driving and Dementia Roadmap may impact how people manage stopping to drive. The findings of this study will be used to improve and ensure that resources, like the Driving and Dementia Roadmap will continue to be available for people with dementia and those who support them.
You are eligible to participate if you are a:
a) Person living with dementia who is still driving or has stopped driving within the past 2 years
b) Family member or friend who is caring for or providing support to a person with dementia who is still driving orhas stopped driving within the past two years
c) Healthcare provider (physician, occupational therapist, nurse practitioner) who cares for people living with dementia
This study explores the air travel experiences of people living with dementia and their travel companions. We want to understand moments that may feel stressful, confusing, or overwhelming when travelling by air. The information gathered will be used to create recommendations for airlines, airports, and policymakers, helping to make air travel more dementia-friendly, supportive, and enjoyable for people living with dementia and their families.
You are eligible to participate if you are:
- A person living with dementia who has flown before, or a travel companion who has supported someone living with dementia during air travel
- Willing to share your experiences in a friendly conversation
- Able to communicate in English
This study aims to evaluate the acceptance and usability of the GuardIO Family Care app, a mobile application designed to support community safety for individuals living with dementia or mild cognitive impairment and their care partners. The study also aims to analyze mobility patterns collected from the app to explore how mobility data can contribute to the early detection of cognitive impairment. The findings will help improve app design, inform care strategies, and support early intervention efforts for individuals living with dementia or MCI.
You are eligible to participate if you:
Are 18 years of age or older
Are living with mild cognitive impairment (MCI) or dementia, or are a care partner of someone with MCI or dementia
Are able to use a smartphone or tablet with the GuardIO app
Are willing to participate in the study activities, including using the app, completing questionnaires, and attending an optional focus group
Can understand and communicate in English (or another supported language, if applicable)
Behavioral and emotional changes often accompany dementia and are a leading cause of long-term care placement, even more so than cognitive decline. This study is the first to explore how family caregivers make treatment decisions in response to these emotional and behavioural symptoms. We are interested in understanding whether caregivers turn to medications, consider non-pharmacological strategies such as environmental modifications, or use a combination of both. Using a quantitative behavioural economics model, this study will examine how caregivers weigh the risks and benefits of different treatment options. We are particularly interested in decision-making related to dopaminergic medications (formerly known as “antipsychotics”), which are commonly prescribed despite known risks for people with dementia. The information gathered will help guide the development of resources to better support family caregivers in navigating treatment decisions. Participation involves completing an anonymous online survey and is open to family caregivers involved in medical decision-making for a relative or close friend with dementia.
Participants will consist of caregivers of individuals with dementia who meet the following eligibility criteria:
Participants must be at least 18 years old,
Participants must be able to read English fluently,
Participants must be a family caregiver (partner, spouse, family member, or close friend) of a
person with dementia
Participants must be involved in the medical decision-making for the person with dementia,
Participants must have access to a desktop computer, laptop, or another device with a physical keyboard and mouse/trackpad,
Participants must not be a professional healthcare provider (e.g., physician, nurse, certified nursing assistant).
Additionally, the person with dementia whom they are assisting must be community-dwelling (i.e., they cannot be residing in a residential or skilled nursing facility).
In this study we aim to explore the motivations and impacts of disclosure a personal diagnosis of dementia or being a care partner on social media. The overall goal of the study is to develop an evidence-based resource to promote benefits of social media for the dementia community while minimizing its harms.
-Identify as an individual living with dementia
-Identify as a care partner
-Are over the age of 19
-Have posted on social media about living with dementia or being a care partner
-Speak English
If you are interested in participating, please contact [email protected] or sign up using the following link: https://ubc.ca1.qualtrics.com/jfe/form/SV_5nGjQ2K27SEZwOi
CAN-PROTECT is a Canada-wide online study recruiting participants and caregivers of persons with dementia to explore how lifestyle, background, and caretaking factors affect our health, quality of life, cognition, behaviour, and function as we age. CAN-PROTECT data will be analyzed and jointly published by the University of Calgary in partnership with the University of Exeter.
- Age 18 years or older
- Reside in Canada
- Have access to a computer/touchscreen device
- Can provide informed consent
- Do not have a diagnosis of dementia
- Additionally, we are enrolling participants who have previously or currently care for persons with dementia for caregiver-specific assessments
- Ability to speak English
It is expected that the information collected during this study will be used in analyses and will be published/presented to the scientific community at meetings and in journals. This information may also be used as part of a submission to regulatory authorities around the world to support the approval of the study intervention for agitation in AD.
You are eligible to participate if you meet the following criteria:
• Age ≥ 55; females must be post-menopausal
• DSM-5 criteria for Major Neurocognitive Disorder due to AD; multiple etiologies (AD and vascular)
• sMMSE ≤ 24
• Clinically significant agitation based on IPA definition
• Stable cognition-enhancing medication for at least 3 months prior to study enrolment
• Availability of a caregiver to accompany participant to study visits and to participate in the study
• Ability to speak English
Follow us: